Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 15Recruiting 10Unknown 7Terminated 6Active not recruiting 4Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3Lymphoid 1Gynecologic 1Endocrine 1

Conditions

Ovarian Neoplasms 13Uterine Cervical Neoplasms 7Endometrial Neoplasms 6Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Vulvar Neoplasms 3Prostatic Neoplasms 3Peritoneal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Carcinoma, Neuroendocrine 2Vulvar Diseases 1Uterine Neoplasms 1Tissue Adhesions 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Ovarian Cysts 1Osteosarcoma 1Obesity 1Neuroendocrine Tumors 1Mesothelioma, Malignant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Mesothelioma, Malignant × Gynecologic × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡